Answers are grounded in this paper and cite their sources.
Currently, tumour stage and grade are the cornerstone indicators of prognosis in bladder cancer. Refinements in histological assessment and new molecular markers are discussed. Evidence is reviewed supporting the notion of two separate molecular pathways to bladder cancer. Deletion of candidate tumour-suppressor genes is an early and common event in primary bladder cancer.
No takes yet. Share an insight, caveat, or question.
Griffiths et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: